Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments
Withdrawn
- Conditions
- anaemia10038158herideritarty hemolytic anaemia
- Registration Number
- NL-OMON41732
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Know and unknown cause of (heriditary) hemolytic anaemia, low Hb, high plasma hemoglobin and/or or family member to be known with (heriditary) hemolytic anaemia
Exclusion Criteria
Transfusion received within 90 days
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method